CMPS COMPASS Pathways Plc - American Depository Shares
Sobre COMPASS Pathways Plc - American Depository Shares Visão geral da empresa da Wikipedia
Compass Pathways, or COMPASS Pathways, is a British pharmaceutical company developing psychedelics as potential medicines. Its main drug candidate, psilocybin (COMP360), has completed phase 3 clinical trials for treatment-resistant depression. The results showed clear benefit to participants as measured on the MADRS depression rating scale. This candidate has received breakthrough therapy status from the U.S. Food and Drug Administration (FDA). It is the most advanced psychedelic drug candidate in development besides Lykos Therapeutics's midomafetamine (MDMA).
Ler mais
Compass Pathways, or COMPASS Pathways, is a British pharmaceutical company developing psychedelics as potential medicines. Its main drug candidate, psilocybin (COMP360), has completed phase 3 clinical trials for treatment-resistant depression. The results showed clear benefit to participants as measured on the MADRS depression rating scale. This candidate has received breakthrough therapy status from the U.S. Food and Drug Administration (FDA). It is the most advanced psychedelic drug candidate in development besides Lykos Therapeutics's midomafetamine (MDMA).
Compass Pathways is the largest company in the psychedelic medicine industry and, in 2020, was the first psychedelic medicine company to be listed on the NASDAQ. It has faced criticism for patenting psychedelic drugs and even certain psilocybin mushroom species. In October 2024, after the FDA rejected Lykos Therapeutics's MDMA for post-traumatic stress disorder (PTSD) New Drug Application (NDA), Compass Pathways said that it would lay off 30% of its workforce and narrow its research focus.
Compass Pathways has entered partnerships with several independent psychedelic academic scientists, including Jason Wallach, Hamilton Morris, and Adam Halberstadt among others, to develop novel psychedelic drugs for potential medical use. Wallach's lab is said to have sought patents for over 200 novel compounds as of May 2024.
Compass Pathways switched from being a nonprofit organization to a for-profit company in 2016. The pharmaceutical company has been backed and funded by a number of tech entrepreneurs such as Peter Thiel. The media outlet Sifted remarks that the biotech billionaire Christian Angermayer was instrumental in the founding of Compass Pathways."
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
CMPS Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
CMPS Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
CMPS Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
- Compra forte 8 33,3%
- Compra 14 58,3%
- Manter 2 8,3%
- Venda 0 0,0%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
16 analistas · 2026-08-16Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 30 de Junho de 2026 | $-1.88 | $-0.41 | -1.5% |
| 31 de Março de 2026 | $0.71 | $-0.39 | 1.1% |
| 31 de Dezembro de 2025 | $-1.00 | $-0.40 | -0.60% |
| 30 de Setembro de 2025 | $-1.44 | $-0.40 | -1.0% |
| 30 de Junho de 2025 | $-0.41 | $-0.44 | 0.03% |
| 31 de Março de 2025 | $-0.38 | $-0.48 | 0.10% |
| 31 de Dezembro de 2024 | $-0.63 | $-0.64 | 0.01% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| CMPS | $663M | -2.2 | — | — | -524.8% | — |
| ROIV | $19.95B | -51.3 | -71.6% | -3629.2% | -6.5% | — |
| BDRX | — | — | — | — | — | — |
| KNSA | $3.15B | 55.0 | 60.1% | 8.7% | 11.1% | — |
| IMCR | $1.76B | -48.9 | 28.9% | -8.9% | -9.2% | — |
| AUTL | — | -1.8 | 644.9% | -381.4% | -109.6% | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 15
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $118M | $119M | $88M | $65M | $44M | $23M | |
| SG&A Expense | $61M | $59M | $49M | $45M | $39M | $28M | |
| Operating Expenses | $179M | $178M | $137M | $110M | $83M | $51M | |
| Operating Income | $-179M | $-178M | $-137M | $-110M | $-83M | $-51M | |
| Interest Expense | · | · | $2M | $0 | $0 | · | |
| Interest Income | $7M | $8M | $5M | · | · | · | |
| Other Non-op | $1M | $823.0K | $255.0K | $19M | $12M | $-9M | |
| Pretax Income | $-290M | $-154M | $-118M | $-91M | $-72M | $-60M | |
| Income Tax | $-2M | $2M | $780.0K | $408.0K | $199.0K | $32.0K | |
| Net Income | $-288M | $-155M | $-118M | $-92M | $-72M | $-60M | |
| EPS (Basic) | $-3.08 | $-2.30 | $-2.32 | $-2.16 | $-1.79 | $-3.55 | |
| EPS (Diluted) | $-3.08 | $-2.30 | $-2.32 | $-2.16 | $-1.79 | $-3.55 | |
| Shares (Basic) | 93,504,836 | 67,482,902 | 51,028,024 | 42,436,292 | 39,997,587 | 16,991,664 | |
| Shares (Diluted) | 93,504,836 | 67,482,902 | 51,028,024 | 42,436,292 | 39,997,587 | 16,991,664 | |
| EBITDA | $-179M | $-178M | $-137M | $-110M | $-83M | · |
Balanço Patrimonial 22
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $150M | $165M | $220M | $143M | $273M | $190M | |
| Prepaid Expense | $42M | $36M | $41M | $48M | $22M | $12M | |
| Other Current Assets | $6M | $4M | $2M | $1M | $1M | $509.0K | |
| Current Assets | $191M | $201M | $261M | $192M | $295M | $202M | |
| PP&E (Net) | · | $189.0K | $423.0K | $617.0K | $398.0K | $245.0K | |
| PP&E (Gross) | · | · | · | $1M | $756.0K | $433.0K | |
| Accum. Depreciation | · | · | · | $530.0K | $358.0K | $188.0K | |
| Other Non-current Assets | $12M | $7M | $7M | $1M | $213.0K | $57.0K | |
| Total Assets | $210M | $214M | $276M | $197M | $301M | $203M | |
| Accounts Payable | $15M | $12M | $6M | $5M | $3M | $3M | |
| Current Liabilities | $248M | $34M | $20M | $16M | $15M | $7M | |
| Capital Leases | $1M | $303.0K | $2M | $418.0K | $1M | · | |
| Total Liabilities | $263M | $59M | $50M | $16M | $16M | $7M | |
| Long-term Debt | $32M | $30M | $29M | $0 | · | · | |
| Total Debt | $32M | $30M | · | · | · | · | |
| Common Stock | $973.0K | $702.0K | $635.0K | · | · | · | |
| Paid-in Capital | $784M | $705M | $622M | $459M | $445M | $279M | |
| Retained Earnings | $-823M | $-535M | $-380M | $-261M | $-170M | $-98M | |
| AOCI | $-15M | $-16M | $-17M | $-17M | $9M | $15M | |
| Stockholders' Equity | $-53M | $155M | $226M | $181M | $284M | $197M | |
| Liabilities + Equity | $210M | $214M | $276M | $197M | $301M | $203M | |
| Shares Outstanding | 96,085,785 | 68,552,215 | 61,943,471 | · | · | · |
Fluxo de Caixa 16
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | · | · | $242.0K | $330.0K | $175.0K | $112.0K | |
| Stock-based Comp | $14M | $20M | $17M | $13M | $9M | $18M | |
| Deferred Tax | $22.0K | $-437.0K | $-1M | $-1M | $-545.0K | $-221.0K | |
| Other Non-cash | · | · | $5M | $-26M | $-4M | · | |
| Operating Cash Flow | $-157M | $-119M | $-97M | $-105M | $-68M | $-41M | |
| CapEx | · | $0 | $66.0K | $596.0K | $334.0K | $131.0K | |
| Investing Cash Flow | · | $0 | $-64.0K | $-596.0K | $-334.0K | $-628.0K | |
| Debt Issued | · | $0 | $30M | $0 | $0 | · | |
| Net Debt Issued | · | $0 | $30M | · | · | · | |
| Stock Issued | $140M | $26M | $145M | $440.0K | $155M | $0 | |
| Net Stock Activity | $140M | $26M | $145M | $440.0K | $155M | · | |
| Financing Cash Flow | $141M | $64M | $174M | $1M | $157M | $194M | |
| Net Change in Cash | $-15M | $-55M | $77M | $-130M | $83M | $165M | |
| Taxes Paid | $755.0K | · | · | · | · | · | |
| Free Cash Flow | · | $-119M | $-97M | $-106M | $-68M | · | |
| Levered FCF | · | · | $-100M | · | · | · |
Lucratividade 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -135.8% | -63.4% | -50.1% | -36.7% | -28.4% | · | |
| ROE | -524.8% | -89.2% | -49.5% | -48.7% | -24.3% | · | |
| ROIC | 836.7% | -97.4% | -61.1% | -61.2% | -29.3% | · |
Liquidez e Solvência 5
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 5.9 | 13.3 | 12.3 | 19.5 | · | |
| Quick Ratio | 0.6 | 4.9 | 11.2 | 9.2 | 18.1 | · | |
| Debt / Equity | -0.6 | 0.2 | · | · | · | · | |
| LT Debt / Equity | -0.3 | 0.2 | · | · | · | · | |
| Interest Coverage | · | · | -62.1 | · | · | · |
Avaliação (TTM) 11
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-288M | $-155M | $-118M | $-92M | $-72M | · | |
| Market Cap | $663M | $259M | · | · | · | · | |
| Enterprise Value | $545M | $124M | · | · | · | · | |
| P/E | -2.2 | -1.6 | -3.8 | -3.7 | -12.3 | · | |
| P/B | -12.5 | 1.7 | · | · | · | · | |
| P / Tangible Book | · | 1.7 | · | · | · | · | |
| P / Cash Flow | -4.2 | -2.2 | · | · | · | · | |
| P / FCF | · | -2.2 | · | · | · | · | |
| EV / EBITDA | -3.0 | -0.7 | · | · | · | · | |
| EV / FCF | · | -1.0 | · | · | · | · | |
| Earnings Yield | -44.6% | -60.9% | -26.5% | -26.9% | -8.1% | · |
Demonstração de Resultados 15
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $29M | $26M | $30M | $27M | $30M | $31M | $32M | $33M | $29M | $25M | $27M | $22M | $20M | $19M | $20M | $14M | |
| SG&A Expense | $23M | $16M | $16M | $13M | $13M | $19M | $16M | $15M | $14M | $14M | $11M | $13M | $13M | $13M | $12M | $12M | |
| Operating Expenses | $52M | $43M | $46M | $41M | $43M | $50M | $48M | $48M | $43M | $39M | $38M | $34M | $33M | $32M | $32M | $26M | |
| Operating Income | $-52M | $-43M | $-46M | $-41M | $-43M | $-50M | $-48M | $-48M | $-43M | $-39M | $-38M | $-34M | $-33M | $-32M | $-32M | $-26M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1M | · | $1M | · | $0 | $0 | $0 | |
| Interest Income | $4M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $638.0K | · | · | · | |
| Other Non-op | $546.0K | $484.0K | $370.0K | $383.0K | $-176.0K | $803.0K | $337.0K | $191.0K | $167.0K | $128.0K | $-8M | $112.0K | $-11.0K | $8M | $1M | $7M | |
| Pretax Income | $-253M | $91M | $-97M | $-138M | $-38M | $-18M | $-42M | $-38M | $-38M | $-35M | $-32M | $-33M | $-28M | $-24M | $-31M | $-18M | |
| Income Tax | $331.0K | $-11.0K | $-3M | $-230.0K | $137.0K | $354.0K | $1M | $173.0K | $176.0K | $222.0K | $394.0K | $62.0K | $194.0K | $130.0K | $92.0K | $120.0K | |
| Net Income | $-254M | $91M | $-94M | $-138M | $-38M | $-18M | $-43M | $-39M | $-38M | $-35M | $-33M | $-33M | $-28M | $-24M | $-31M | $-18M | |
| EPS (Basic) | $-1.88 | $0.71 | $-1.03 | $-1.44 | $-0.41 | $-0.20 | $-0.63 | $-0.56 | $-0.56 | $-0.55 | $618.92 | $-0.67 | $-620.00 | $-0.57 | $-0.73 | $-0.43 | |
| EPS (Diluted) | $-1.88 | $-0.30 | $-0.99 | $-1.44 | $-0.41 | $-0.24 | $-0.63 | $-0.56 | $-0.56 | $-0.55 | $618.92 | $-0.67 | $-620.00 | $-0.57 | $-0.73 | $-0.43 | |
| Shares (Basic) | 135,039,810 | 110,064,581 | -184,367,003 | 95,337,993 | 93,341,594 | 89,192,252 | -133,505,758 | 68,395,343 | 68,371,139 | 64,222,178 | -86,896,934 | 49,633,104 | 45,565,991 | 42,725,863 | -84,601,113 | 42,525,855 | |
| Shares (Diluted) | 135,039,810 | 130,266,693 | -193,816,374 | 95,337,993 | 93,341,594 | 98,641,623 | -133,505,758 | 68,395,343 | 68,371,139 | 64,222,178 | -86,896,934 | 49,633,104 | 45,565,991 | 42,725,863 | -84,601,113 | 42,525,855 | |
| EBITDA | $-52M | $-43M | · | $-41M | $-43M | $-50M | · | $-48M | $-43M | $-39M | · | $-34M | $-33M | $-32M | · | $-25M |
Balanço Patrimonial 22
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $433M | $466M | $150M | $186M | $222M | $260M | $165M | $207M | $229M | $263M | $220M | $248M | $148M | $117M | $143M | $173M | |
| Prepaid Expense | $42M | $44M | $42M | $56M | $54M | $45M | $36M | $26M | $36M | $31M | $41M | $36M | $45M | $50M | $48M | $45M | |
| Other Current Assets | $8M | $7M | $6M | $3M | $2M | $2M | $4M | $2M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Current Assets | $476M | $511M | $191M | $242M | $276M | $305M | $201M | $234M | $265M | $296M | $261M | $285M | $194M | $168M | $192M | $218M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | $359.0K | $423.0K | $309.0K | $482.0K | $612.0K | $617.0K | $555.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $950.0K | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $395.0K | |
| Other Non-current Assets | $20M | $14M | $12M | $5M | $9M | $8M | $7M | $7M | $6M | $6M | $7M | $6M | $7M | $212.0K | $1M | $299.0K | |
| Total Assets | $505M | $532M | $210M | $256M | $294M | $319M | $214M | $247M | $279M | $309M | $276M | $299M | $210M | $173M | $197M | $225M | |
| Accounts Payable | $12M | $11M | $15M | $5M | $11M | $9M | $12M | $8M | $8M | $9M | $6M | $4M | $2M | $4M | $5M | $20M | |
| Current Liabilities | $367M | $154M | $248M | $197M | $31M | $30M | $34M | $26M | $22M | $19M | $20M | $15M | $13M | $11M | $16M | $30M | |
| Capital Leases | $2M | $779.0K | $1M | $2M | $2M | $259.0K | $303.0K | $459.0K | $799.0K | $1M | $2M | $2M | $3M | $412.0K | $418.0K | $425.0K | |
| Total Liabilities | $420M | $205M | $263M | $218M | $131M | $124M | $59M | $54M | $52M | $50M | $50M | $46M | $43M | $12M | $16M | $30M | |
| Long-term Debt | $51M | $50M | $32M | $31M | $31M | $31M | $30M | $30M | $29M | $29M | $29M | $28M | $28M | · | $0 | · | |
| Total Debt | $51M | $50M | · | $31M | $31M | $31M | · | $28M | · | · | · | · | · | · | · | · | |
| Common Stock | $1M | $1M | $973.0K | $973.0K | $946.0K | $938.0K | $702.0K | $699.0K | $699.0K | $699.0K | $635.0K | · | · | · | · | · | |
| Paid-in Capital | $1.08B | $1.07B | $784M | $781M | $767M | $763M | $705M | $700M | $695M | $690M | $622M | $617M | $496M | $464M | $459M | $455M | |
| Retained Earnings | $-985M | $-731M | $-823M | $-729M | $-591M | $-553M | $-535M | $-491M | $-453M | $-415M | $-380M | $-347M | $-314M | $-285M | $-261M | $-230M | |
| AOCI | $-15M | $-15M | $-15M | $-15M | $-15M | $-16M | $-16M | $-17M | $-17M | $-17M | $-17M | $-17M | $-17M | $-17M | $-17M | $-31M | |
| Stockholders' Equity | $85M | $327M | $-53M | $38M | $163M | $195M | $155M | $193M | $226M | $259M | $226M | $253M | $166M | $162M | $181M | $195M | |
| Liabilities + Equity | $505M | $532M | $210M | $256M | $294M | $319M | $214M | $247M | $279M | $309M | $276M | $299M | $210M | $173M | $197M | $225M | |
| Shares Outstanding | 135,722,306 | 134,923,295 | 96,085,785 | 96,002,044 | 93,586,348 | 92,848,326 | 68,552,215 | 68,409,068 | 68,387,469 | 68,342,534 | 61,943,471 | · | · | · | · | · |
Fluxo de Caixa 14
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | $59.0K | $63.0K | $61.0K | · | $186.0K | $110.0K | $48.0K | $76.0K | $100.0K | |
| Stock-based Comp | $4M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | $5M | $4M | $4M | $5M | $4M | $3M | $4M | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $9M | · | · | · | $-8M | · | · | |
| Operating Cash Flow | $-40M | $-48M | $-38M | $-35M | $-39M | $-46M | $-42M | $-22M | $-34M | $-21M | $-28M | $-17M | $-25M | $-28M | $-45M | $-19M | |
| CapEx | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $18.0K | $19.0K | $29.0K | $107.0K | $-5.0K | |
| Investing Cash Flow | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $-18.0K | $-17.0K | $-29.0K | $-107.0K | $5.0K | |
| Debt Issued | $0 | $19M | · | · | $0 | $0 | · | $0 | · | · | $0 | $0 | · | · | $0 | $0 | |
| Net Debt Issued | · | $19M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | · | $141M | $0 | $0 | $0 | $140M | $0 | $0 | $0 | $26M | $-41.0K | $117M | $27M | $1M | $440.0K | $0 | |
| Net Stock Activity | · | $141M | · | · | · | $140M | · | · | · | $26M | · | · | · | $1M | · | · | |
| Financing Cash Flow | $8M | $362M | $187.0K | $0 | $166.0K | $140M | $155.0K | $-53.0K | $210.0K | $64M | $41.0K | $117M | $56M | $1M | $639.0K | $-1.0K | |
| Net Change in Cash | $-33M | $316M | $-36M | $-36M | $-38M | $95M | $-42M | $-22M | $-34M | $43M | $-28M | $100M | $31M | $-26M | $-30M | $-34M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-21M | · | · | · | $-28M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-22M | · | · | · | · | · | · |
Lucratividade 3
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -63.6% | 21.4% | · | -54.8% | -13.4% | -5.7% | · | -14.1% | -15.6% | -14.6% | · | -12.8% | -12.6% | -10.9% | · | -16.4% | |
| ROE | -205.4% | 34.9% | · | -119.4% | -19.8% | -7.9% | · | -17.2% | -19.4% | -16.7% | · | -14.9% | -14.5% | -11.5% | · | -18.9% | |
| ROIC | -38.8% | -11.4% | · | -58.8% | -22.3% | -22.4% | · | -21.8% | -19.2% | -15.0% | · | -13.5% | -19.8% | -19.8% | · | -13.2% |
Liquidez e Solvência 5
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 3.3 | · | 1.2 | 8.8 | 10.2 | · | 8.9 | 12.0 | 15.2 | · | 18.6 | 15.2 | 14.9 | · | 7.4 | |
| Quick Ratio | 1.2 | 3.0 | · | 0.9 | 7.1 | 8.7 | · | 7.9 | 10.4 | 13.5 | · | 16.2 | 11.6 | 10.4 | · | 5.9 | |
| Debt / Equity | 0.6 | 0.2 | · | 0.8 | 0.2 | 0.2 | · | 0.1 | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.6 | 0.2 | · | 0.5 | 0.1 | 0.1 | · | 0.1 | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -35.1 | · | -31.5 | · | · | · | · |
Avaliação (TTM) 10
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-339M | $-103M | · | $-232M | $-133M | $-130M | · | $-145M | $-135M | $-121M | · | $-104M | $-92M | $-85M | · | $-76M | |
| Market Cap | $1.92B | $746M | · | $550M | $262M | $266M | · | $431M | $413M | $569M | · | · | · | · | · | · | |
| Enterprise Value | $1.54B | $331M | · | $395M | $71M | $36M | · | $252M | · | · | · | · | · | · | · | · | |
| P/E | -3.5 | -2.3 | · | -2.2 | -1.6 | -1.5 | · | -2.7 | -0.0 | -0.0 | · | -0.0 | -0.0 | -5.0 | · | -5.9 | |
| P/B | 22.7 | 2.3 | · | 14.6 | 1.6 | 1.4 | · | 2.2 | 1.8 | 2.2 | · | · | · | · | · | · | |
| P / Tangible Book | 22.7 | 2.3 | · | 14.6 | 1.6 | 1.4 | · | 2.2 | 1.8 | 2.2 | · | · | · | · | · | · | |
| P / Cash Flow | · | -15.6 | · | · | · | -5.8 | · | · | · | -27.3 | · | · | · | · | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | -27.3 | · | · | · | · | · | · | |
| EV / EBITDA | -29.4 | -7.7 | · | -9.8 | -1.7 | -0.7 | · | -5.3 | · | · | · | · | · | · | · | · | |
| Earnings Yield | -28.5% | -43.2% | · | -46.2% | -63.2% | -66.8% | · | -37.1% | -10294.4% | -7473.4% | · | -8401.0% | -7506.0% | -20.1% | · | -16.9% |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Lucro líquido | $-288M | $-155M | $-118M | $-92M | $-72M |
| EPS Diluído | $-3.08 | $-2.30 | $-2.32 | $-2.16 | $-1.79 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | -0.6 | 0.2 | — | — | — |
| Índice de liquidez corrente | 0.8 | 5.9 | 13.3 | 12.3 | 19.5 |
| Índice de Liquidez Seca | 0.6 | 4.9 | 11.2 | 9.2 | 18.1 |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | — | $-119M | $-97M | $-106M | $-68M |
Últimas notícias Notícias recentes mencionando esta empresa
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 250 declarantes · $1.3B total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 66 (+6 vs trimestre anterior) | 30 (+7 vs trimestre anterior) | 77 (+3 vs trimestre anterior) | 53 (+26 vs trimestre anterior) | -2.0M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| Deep Track Capital, LP | $172.085.168 | 12.161.496 | 13,73% | Ações |
| RTW INVESTMENTS, LP | $151.418.782 | 10.700.974 | 12,08% | Ações |
| BIT Capital GmbH | $89.835.478 | 6.348.797 | 7,17% | Ações |
| TANG CAPITAL MANAGEMENT LLC | $70.750.000 | 5.000.000 | 5,65% | Ações |
| TWO SIGMA INVESTMENTS, LP | $63.257.363 | 4.470.485 | 5,05% | Ações |
| ARK Investment Management LLC | $48.845.310 | 3.451.965 | 3,90% | Ações |
| Point72 Asset Management, L.P. | $37.085.424 | 2.620.878 | 2,96% | Ações |
| Logos Global Management LP | $31.837.500 | 2.250.000 | 2,54% | Ações |
| Eagle Health Investments LP | $29.155.042 | 2.060.427 | 2,33% | Ações |
| DAFNA Capital Management LLC | $28.469.121 | 2.011.952 | 2,27% | Ações |
| BANK OF AMERICA CORP /DE/ | $28.339.691 | 2.002.805 | 2,26% | Ações |
| Caption Management, LLC | $27.544.390 | 1.946.600 | 2,20% | Opção de compra |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $26.855.285 | 1.897.900 | 2,14% | Opção de compra |
| NEXTBio Capital Management LP | $25.126.990 | 1.775.759 | 2,00% | Ações |
| MARSHALL WACE, LLP | $20.935.350 | 1.479.530 | 1,67% | Ações |
| Aisling Capital Management LP | $20.267.554 | 1.432.336 | 1,62% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $20.261.229 | 1.431.889 | 1,62% | Ações |
| Candriam S.C.A. | $18.013.686 | 1.274.278 | 1,44% | Ações |
| Woodline Partners LP | $15.366.957 | 1.086.004 | 1,23% | Ações |
| Jefferies Financial Group Inc. | $14.070.661 | 994.393 | 1,12% | Ações |
| Trexquant Investment LP | $12.171.236 | 860.158 | 0,97% | Ações |
| Kalehua Capital Management LLC | $11.598.642 | 819.692 | 0,93% | Ações |
| MILLENNIUM MANAGEMENT LLC | $10.909.466 | 770.987 | 0,87% | Ações |
| Caption Management, LLC | $10.699.041 | 756.116 | 0,85% | Ações |
| Eversept Partners, LP | $9.520.474 | 672.825 | 0,76% | Ações |
| Propel Bio Management, LLC | $8.109.167 | 573.086 | 0,65% | Ações |
| Creek Drive Management Group LLC | $8.093.800 | 572.000 | 0,65% | Ações |
| Occam Crest Management LP | $7.739.000 | 710.000 | 0,62% | Ações |
| CITADEL ADVISORS LLC | $7.567.420 | 534.800 | 0,60% | Opção de compra |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7.140.090 | 504.600 | 0,57% | Opção de venda |
| SILVERARC CAPITAL MANAGEMENT, LLC | $7.122.855 | 503.382 | 0,57% | Ações |
| JANE STREET GROUP, LLC | $7.075.821 | 500.058 | 0,56% | Ações |
| Qube Research & Technologies Ltd | $7.070.415 | 499.676 | 0,56% | Ações |
| Walleye Capital LLC | $6.893.385 | 487.165 | 0,55% | Ações |
| Ensign Peak Advisors, Inc | $6.716.340 | 474.653 | 0,54% | Ações |
| Blue Owl Capital Holdings LP | $6.367.500 | 450.000 | 0,51% | Ações |
| AdvisorShares Investments LLC | $5.962.060 | 421.347 | 0,48% | Ações |
| CITADEL ADVISORS LLC | $5.952.679 | 420.684 | 0,47% | Ações |
| TWO SIGMA ADVISERS, LP | $5.909.850 | 856.500 | 0,47% | Ações |
| GOLDMAN SACHS GROUP INC | $5.540.956 | 391.587 | 0,44% | Ações |
| HighVista Strategies LLC | $5.251.349 | 371.120 | 0,42% | Ações |
| Legal & General Group Plc | $4.700.154 | 332.206 | 0,38% | Ações |
| Sumitomo Mitsui Trust Group, Inc. | $4.573.407 | 323.209 | 0,36% | Ações |
| Amova Asset Management Americas, Inc. | $4.517.334 | 319.472 | 0,36% | Ações |
| Squadron Capital Management LLC | $4.315.750 | 305.000 | 0,34% | Opção de compra |
| Affinity Asset Advisors, LLC | $4.261.739 | 301.183 | 0,34% | Ações |
| SEVEN GRAND MANAGERS, LLC | $4.245.000 | 300.000 | 0,34% | Ações |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $4.245.000 | 300.000 | 0,34% | Ações |
| Squadron Capital Management LLC | $4.245.000 | 300.000 | 0,34% | Ações |
| AMERIPRISE FINANCIAL INC | $4.081.271 | 288.429 | 0,33% | Ações |
| JANE STREET GROUP, LLC | $4.079.445 | 288.300 | 0,33% | Opção de compra |
| STEMPOINT CAPITAL LP | $4.029.481 | 284.769 | 0,32% | Ações |
| TORONTO DOMINION BANK | $3.930.233 | 277.755 | 0,31% | Ações |
| ROYCE & ASSOCIATES LP | $3.778.885 | 267.059 | 0,30% | Ações |
| PFM Health Sciences, LP | $3.503.384 | 247.589 | 0,28% | Ações |
| D. E. Shaw & Co., Inc. | $3.408.367 | 240.874 | 0,27% | Ações |
| Brown University | $3.030.930 | 214.200 | 0,24% | Ações |
| MORGAN STANLEY | $2.973.693 | 210.155 | 0,24% | Ações |
| Caption Management, LLC | $2.950.275 | 208.500 | 0,24% | Opção de venda |
| HEIGHTS CAPITAL MANAGEMENT, INC | $2.913.938 | 205.932 | 0,23% | Ações |
| CITADEL ADVISORS LLC | $2.695.575 | 190.500 | 0,22% | Opção de venda |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | $2.481.528 | 175.373 | 0,20% | Ações |
| Engineers Gate Manager LP | $2.432.343 | 171.897 | 0,19% | Ações |
| Y-Intercept (Hong Kong) Ltd | $2.378.474 | 168.090 | 0,19% | Ações |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | $2.122.500 | 150.000 | 0,17% | Ações |
| Squarepoint Ops LLC | $1.962.195 | 138.671 | 0,16% | Ações |
| Balyasny Asset Management L.P. | $1.959.492 | 138.480 | 0,16% | Ações |
| ALPS ADVISORS INC | $1.930.937 | 136.462 | 0,15% | Ações |
| Founders Fund VII Management, LLC | $1.924.272 | 278.880 | 0,15% | Ações |
| K2 PRINCIPAL FUND, L.P. | $1.911.665 | 135.100 | 0,15% | Ações |
| WELLS FARGO & COMPANY/MN | $1.897.246 | 134.081 | 0,15% | Ações |
| CenterBook Partners LP | $1.777.155 | 125.594 | 0,14% | Ações |
| Creek Drive Management Group LLC | $1.698.000 | 120.000 | 0,14% | Opção de compra |
| BANK OF MONTREAL /CAN/ | $1.686.991 | 119.222 | 0,13% | Ações |
| ENVESTNET ASSET MANAGEMENT INC | $1.639.118 | 115.839 | 0,13% | Ações |
| Palo Alto Investors LP | $1.635.966 | 115.616 | 0,13% | Ações |
| Simplify Asset Management Inc. | $1.617.076 | 114.281 | 0,13% | Ações |
| LPL Financial LLC | $1.550.387 | 109.568 | 0,12% | Ações |
| GROUP ONE TRADING LLC | $1.390.917 | 98.298 | 0,11% | Ações |
| Susquehanna Portfolio Strategies, LLC | $1.341.448 | 94.802 | 0,11% | Ações |
| CreativeOne Wealth, LLC | $1.336.312 | 94.439 | 0,11% | Ações |
| STABLEFORD CAPITAL II LLC | $1.300.003 | 91.873 | 0,10% | Ações |
| STATE STREET CORP | $1.150.098 | 81.279 | 0,09% | Ações |
| Lion Point Capital, LP | $1.132.000 | 80.000 | 0,09% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $1.063.896 | 75.187 | 0,08% | Ações |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | $1.016.635 | 71.847 | 0,08% | Ações |
| DLD Asset Management, LP | $990.500 | 70.000 | 0,08% | Opção de venda |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $941.852 | 66.562 | 0,08% | Ações |
| Aquatic Capital Management LLC | $922.297 | 65.180 | 0,07% | Ações |
| JANE STREET GROUP, LLC | $915.505 | 64.700 | 0,07% | Opção de venda |
| Dorsey Wright & Associates | $883.653 | 62.449 | 0,07% | Ações |
| Campbell & CO Investment Adviser LLC | $874.696 | 61.816 | 0,07% | Ações |
| STIFEL FINANCIAL CORP | $855.639 | 60.469 | 0,07% | Ações |
| Intellectus Partners, LLC | $841.925 | 59.500 | 0,07% | Ações |
| DCF Advisers, LLC | $767.638 | 54.250 | 0,06% | Ações |
| CIBC WORLD MARKET INC. | $737.357 | 52.110 | 0,06% | Ações |
| NATIONAL BANK OF CANADA /FI/ | $731.420 | 51.727 | 0,06% | Ações |
| FLAX POND CAPITAL, LLC | $728.951 | 51.516 | 0,06% | Ações |
| EXCHANGE TRADED CONCEPTS, LLC | $708.943 | 50.102 | 0,06% | Ações |
| PEAK6 LLC | $707.500 | 50.000 | 0,06% | Opção de compra |
Executivos da empresa 9 insiders · 0 diretores · 0 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Kabir Nath | — | 3 de Agosto de 2026 F | 361.028 | 0 | 0 | $0 |
| Robert Mcquade | — | 27 de Maio de 2026 A | — | 0 | 0 | $0 |
| Kathleen Tregoning | — | 27 de Maio de 2026 A | — | 0 | 0 | $0 |
| Daphne Karydas | — | 27 de Maio de 2026 A | — | 0 | 0 | $0 |
| Justin D. Gover | — | 27 de Maio de 2026 A | — | 0 | 0 | $0 |
| David Y Norton | — | 27 de Maio de 2026 A | — | 0 | 0 | $0 |
| Wayne Joseph Riley | — | 27 de Maio de 2026 A | — | 0 | 0 | $0 |
| Gino Santini | — | 27 de Maio de 2026 A | — | 0 | 0 | $0 |
| Jeffrey M Jonas | — | 27 de Maio de 2026 A | — | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 1 participação
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| AtaiBeckley Inc. | 17 de Fevereiro de 2026 | 4,96% | Emenda | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 6 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| ARKG · ARK ETF Trust | 2,43% | 3.316.076 NS | 30 de Abril de 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,99% | 40.950 NS | 30 de Abril de 2026 | N-PORT |
| BIB · ProShares Trust | 0,06% | 3.487 NS | 31 de Maio de 2026 | N-PORT |
| APIE · Trust for Professional Managers | 0,03% | 21.455 NS | 31 de Maio de 2026 | N-PORT |
| IBB · iShares Trust | — | — | 18 de Agosto de 2026 | Diário |
| IBBQ · Invesco Exchange-Traded Fund Trust … | — | — | 20 de Julho de 2026 | Diário |